ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,296Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 570

$1.58M Total Retail Price of All Prescriptions

Rank: 8 out of 570

496 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

21% of this provider’s 496 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

46% of this provider’s 496 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 14,809 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 52%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $124 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
HYDROCODONE-ACETAMINOPHEN 1,730 861 S3 1 9
LISINOPRIL 882 689 2 11
AMLODIPINE BESYLATE 702 529 3 7
SIMVASTATIN 636 507 4 6
OMEPRAZOLE 606 457 5 5
METFORMIN HCL 517 374 6 14
PRAVASTATIN SODIUM 517 381 6 43
HYDROCHLOROTHIAZIDE 516 355 8 26
LEVOTHYROXINE SODIUM 454 321 9 8
FUROSEMIDE 448 338 10 10
ZOLPIDEM TARTRATE 419 235 11 17
CARVEDILOL 417 326 12 33
POTASSIUM CHLORIDE 393 309 13 24
CARISOPRODOL 357 48 R 14 66
GABAPENTIN 353 213 15 25
METOPROLOL TARTRATE 276 190 16 18
ALENDRONATE SODIUM 267 215 17 28
MORPHINE SULFATE ER 258 88 S2 18 140
TERAZOSIN HCL 253 218 19 105
OXYCODONE HCL 249 95 S2 20 154
LOSARTAN POTASSIUM 225 185 21 23
WARFARIN SODIUM 225 199 21 16
PROAIR HFA 203 138 23 4
OXYCONTIN 195 75 S2 24 196
FENOFIBRATE 194 134 25 109
ATORVASTATIN CALCIUM 189 159 26 20
FAMOTIDINE 183 125 27 41
BENAZEPRIL HCL 182 134 28 42
ADVAIR DISKUS 171 105 29 2
TAMSULOSIN HCL 168 137 30 37
SPIRIVA 163 109 31 1
ATENOLOL 153 109 32 22
JANUVIA 147 98 33 58
LOVASTATIN 141 120 34 34
DIOVAN 134 94 35 27
TRAMADOL HCL 134 111 35 31
AZITHROMYCIN 131 79 37 12
CRESTOR 128 94 38 60
TRAZODONE HCL 126 53 39 80
IBUPROFEN 118 20 40 53
ALLOPURINOL 118 99 40 55
DILTIAZEM ER 117 96 42 186
CITALOPRAM HBR 117 61 42 82
CLOPIDOGREL 115 89 44 48
CYMBALTA 114 58 45 93
DIGOXIN 100 79 46 46
COMBIVENT 97 53 47 36
ZETIA 97 56 47 135
TRICOR 97 97 47 151
PLAVIX 96 58 50 68
FLUTICASONE PROPIONATE 96 35 50 19
AMLODIPINE BESYLATE-BENAZEPRIL 94 56 52 283
GLYBURIDE 89 54 R 53 71
PREDNISONE 89 56 53 3
LACTULOSE 87 68 55 90
DONEPEZIL HCL 87 70 55 35
ACTOS 86 68 57 146
NIFEDIPINE ER 84 65 58 101
NAMENDA 83 82 59 50
RANITIDINE HCL 82 47 60 88
NEXIUM 79 35 61 45
METOPROLOL SUCCINATE 79 67 61 44
ENALAPRIL MALEATE 78 75 63 78
BACLOFEN 78 35 63 84
CLONIDINE HCL 76 53 65 49
DILTIAZEM 24HR ER 76 69 65 224
METHADONE HCL 74 26 S2 67 131
LANTUS SOLOSTAR 74 55 67 187
SINGULAIR 73 57 69 15
PANTOPRAZOLE SODIUM 72 56 70 21
ACETAMINOPHEN-CODEINE 71 57 S3 71 75
ONGLYZA 70 47 72 306
PAROXETINE HCL 70 52 72 79
NAPROXEN 67 53 74 70
MEGESTROL ACETATE 67 58 R 74 63
PROMETHAZINE HCL 66 27 R 76 144
NITROSTAT 65 40 77 230
SERTRALINE HCL 65 37 77 61
GLIPIZIDE 65 44 77 51
VENTOLIN HFA 64 47 80 38
FLUOXETINE HCL 64 50 80 94
THEOPHYLLINE ANHYDROUS 62 43 82 47
PRADAXA 62 56 82 217
DILTIAZEM 24HR CD 62 50 82 136
ACARBOSE 60 36 85 269
GLIMEPIRIDE 58 33 86 76
TRIAMCINOLONE ACETONIDE 58 17 86 62
NIASPAN 57 30 88 264
METOCLOPRAMIDE HCL 57 21 88 81
LANTUS 56 37 90 52
LIPITOR 56 56 90 139
PREMARIN 55 36 R 92 169
PEN NEEDLE 55 28 92 233
CIPROFLOXACIN HCL 53 38 94 56
KLOR-CON 10 53 41 94 197
LYRICA 53 30 94 194
PHENYTOIN SODIUM EXTENDED 53 38 94 130
INSULIN SYRINGE 53 27 94 115
OXYBUTYNIN CHLORIDE 53 40 94 201
SPS 52 46 100 348
QVAR 52 20 100 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.